identification of allele-specific rnai effectors targeting genetic forms of parkinsons disease识别allele-specific rnai效应器针对帕金森病的基因形式.pdfVIP

Identification of Allele-Specific RNAi Effectors Targeting Genetic Forms of Parkinson’s Disease 1,2 1 Christopher R. Sibley , Matthew J. A. Wood * 1 Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, United Kingdom, 2 MRC Laboratory of Molecular Biology, Cambridge, United Kingdom Abstract Parkinson’s disease (PD) is a progressive neurological disorder affecting an estimated 5–10 million people worldwide. Recent evidence has implicated several genes that directly cause or increase susceptibility to PD. As well as advancing understanding of the genetic aetiology of PD these findings suggest new ways to modify the disease course, in some cases through genetic manipulation. Here we generated a ‘walk-through’ series of RNA Pol III-expressed shRNAs targeting both the a-synuclein A30P and LRRK2 G2019S PD-associated mutations. Allele-specific discrimination of the a-synuclein A30P mutation was achieved with alignments at position 10, 13 and 14 in two model systems, including a heterozygous model mimicking the disease setting, whilst 59RACE was used to confirm stated alignments. Discrimination of the most common PD-linked LRRK2 G2019S mutation was assessed in hemizygous dual-luciferase assays and showed that alignment of the mutation opposite position 4 of the antisense species produced robust discrimination of alleles at all time points studied. Discrimination at this position was subsequently confirmed using siRNAs, where up to 10-fold discrimination was seen. The results suggest that RNAi-mediated silencing of PD-associated autosomal dominant genes could be a novel therapeutic approach for the treatment of the relevant clinical cases of PD in future. Citation: Sibley CR, Wood MJA (2011) Identification of Allele-Spe